AQR Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.2M | Sell |
|
|||||
|
2025
Q1 | $69.6M | Sell |
|
|||||
|
2024
Q4 | $99M | Sell |
|
|||||
|
2024
Q3 | $223M | Sell |
|
|||||
|
2024
Q2 | $251M | Sell |
|
|||||
|
2024
Q1 | $279M | Buy |
|
|||||
|
2023
Q4 | $262M | Buy |
|
|||||
|
2023
Q3 | $224M | Buy |
|
|||||
|
2023
Q2 | $216M | Buy |
|
|||||
|
2023
Q1 | $180M | Sell |
|
|||||
|
2022
Q4 | $169M | Buy |
|
|||||
|
2022
Q3 | $143M | Sell |
|
|||||
|
2022
Q2 | $144M | Buy |
|
|||||
|
2022
Q1 | $129M | Sell |
|
|||||
|
2021
Q4 | $131M | Sell |
|
|||||
|
2021
Q3 | $116M | Sell |
|
|||||
|
2021
Q2 | $139M | Sell |
|
|||||
|
2021
Q1 | $195M | Buy |
|
|||||
|
2020
Q4 | $129M | Sell |
|
|||||
|
2020
Q3 | $175M | Buy |
|
|||||
|
2020
Q2 | $176M | Buy |
|
|||||
|
2020
Q1 | $138M | Buy |
|
|||||
|
2019
Q4 | $89.6M | Buy |
|
|||||
|
2019
Q3 | $45.8M | Buy |
|
|||||
|
2019
Q2 | $45M | Sell |
|
|||||
|
2019
Q1 | $81M | Sell |
|
|||||
|
2018
Q4 | $126M | Sell |
|
|||||
|
2018
Q3 | $247M | Buy |
|
|||||
|
2018
Q2 | $141M | Sell |
|
|||||
|
2018
Q1 | $206M | Sell |
|
|||||
|
2017
Q4 | $227M | Sell |
|
|||||
|
2017
Q3 | $287M | Buy |
|
|||||
|
2017
Q2 | $109M | Buy |
|
|||||
|
2017
Q1 | $26.5M | Buy |
|
|||||
|
2016
Q4 | $8.63M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $5.84M | Sell |
|
|||||
|
2015
Q3 | $49.3M | Sell |
|
|||||
|
2015
Q2 | $101M | Sell |
|
|||||
|
2015
Q1 | $106M | Buy |
|
|||||
|
2014
Q4 | $74.5M | Sell |
|
|||||
|
2014
Q3 | $75.2M | Buy |
|
|||||
|
2014
Q2 | $45.8M | Buy |
|
|||||
|
2014
Q1 | $32.2M | Sell |
|
|||||
|
2013
Q4 | $38.7M | Buy |
|
|||||
|
2013
Q3 | $33.4M | Sell |
|
|||||
|
2013
Q2 | $40.9M | Buy |
|